[(2S)-1-[[(4S,7S,9aS)-8,8-dimethyl-5-oxo-7-[[(1S)-1-phenyl-2-prop-2-ynoxyethyl]carbamoyl]-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepin-4-yl]amino]-1-oxopropan-2-yl]-methylcarbamic acid

C27H36N4O6S — CID 146596791

IUPAC[(2S)-1-[[(4S,7S,9aS)-8,8-dimethyl-5-oxo-7-[[(1S)-1-phenyl-2-prop-2-ynoxyethyl]carbamoyl]-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepin-4-yl]amino]-1-oxopropan-2-yl]-methylcarbamic acid
SMILESC#CCOC[C@@H](NC(=O)[C@H]1N2C(=O)[C@@H](NC(=O)[C@H](C)N(C)C(=O)O)CCS[C@H]2CC1(C)C)c1ccccc1
InChIInChI=1S/C27H36N4O6S/c1-6-13-37-16-20(18-10-8-7-9-11-18)29-24(33)22-27(3,4)15-21-31(22)25(34)19(12-14-38-21)28-23(32)17(2)30(5)26(35)36/h1,7-11,17,19-22H,12-16H2,2-5H3,(H,28,32)(H,29,33)(H,35,36)/t17-,19-,20+,21-,22+/m0/s1
InChIKeyGEFSRSARSDNUEO-TXZRGUEPSA-N
MW544.67 g/mol
LogP2.07
Rot. Bonds9

About [(2S)-1-[[(4S,7S,9aS)-8,8-dimethyl-5-oxo-7-[[(1S)-1-phenyl-2-prop-2-ynoxyethyl]carbamoyl]-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepin-4-yl]amino]-1-oxopropan-2-yl]-methylcarbamic acid

[(2S)-1-[[(4S,7S,9aS)-8,8-dimethyl-5-oxo-7-[[(1S)-1-phenyl-2-prop-2-ynoxyethyl]carbamoyl]-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepin-4-yl]amino]-1-oxopropan-2-yl]-methylcarbamic acid (PubChem CID 146596791) has the molecular formula C27H36N4O6S and a molecular weight of 544.67 g/mol. Its IUPAC name is [(2S)-1-[[(4S,7S,9aS)-8,8-dimethyl-5-oxo-7-[[(1S)-1-phenyl-2-prop-2-ynoxyethyl]carbamoyl]-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepin-4-yl]amino]-1-oxopropan-2-yl]-methylcarbamic acid.

Molecular Properties

Compound Name[(2S)-1-[[(4S,7S,9aS)-8,8-dimethyl-5-oxo-7-[[(1S)-1-phenyl-2-prop-2-ynoxyethyl]carbamoyl]-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepin-4-yl]amino]-1-oxopropan-2-yl]-methylcarbamic acid
PubChem CID146596791
Molecular FormulaC27H36N4O6S
Molecular Weight544.67 g/mol
Exact Mass544.24
IUPAC Name[(2S)-1-[[(4S,7S,9aS)-8,8-dimethyl-5-oxo-7-[[(1S)-1-phenyl-2-prop-2-ynoxyethyl]carbamoyl]-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepin-4-yl]amino]-1-oxopropan-2-yl]-methylcarbamic acid
SMILESC#CCOC[C@@H](NC(=O)[C@H]1N2C(=O)[C@@H](NC(=O)[C@H](C)N(C)C(=O)O)CCS[C@H]2CC1(C)C)c1ccccc1
InChIInChI=1S/C27H36N4O6S/c1-6-13-37-16-20(18-10-8-7-9-11-18)29-24(33)22-27(3,4)15-21-31(22)25(34)19(12-14-38-21)28-23(32)17(2)30(5)26(35)36/h1,7-11,17,19-22H,12-16H2,2-5H3,(H,28,32)(H,29,33)(H,35,36)/t17-,19-,20+,21-,22+/m0/s1
InChIKeyGEFSRSARSDNUEO-TXZRGUEPSA-N
XLogP2.07
TPSA128.28 Ų
H-Bond Donors3
H-Bond Acceptors6
Rotatable Bonds9
Heavy Atoms38
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500544.67
LogP ≤ 52.07
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze [(2S)-1-[[(4S,7S,9aS)-8,8-dimethyl-5-oxo-7-[[(1S)-1-phenyl-2-prop-2-ynoxyethyl]carbamoyl]-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepin-4-yl]amino]-1-oxopropan-2-yl]-methylcarbamic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2S)-1-[[(4S,7S,9aS)-8,8-dimethyl-5-oxo-7-[[(1S)-1-phenyl-2-prop-2-ynoxyethyl]carbamoyl]-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepin-4-yl]amino]-1-oxopropan-2-yl]-methylcarbamic acid?
The IUPAC name of [(2S)-1-[[(4S,7S,9aS)-8,8-dimethyl-5-oxo-7-[[(1S)-1-phenyl-2-prop-2-ynoxyethyl]carbamoyl]-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepin-4-yl]amino]-1-oxopropan-2-yl]-methylcarbamic acid (CID 146596791) is [(2S)-1-[[(4S,7S,9aS)-8,8-dimethyl-5-oxo-7-[[(1S)-1-phenyl-2-prop-2-ynoxyethyl]carbamoyl]-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepin-4-yl]amino]-1-oxopropan-2-yl]-methylcarbamic acid.
What is the SMILES notation for [(2S)-1-[[(4S,7S,9aS)-8,8-dimethyl-5-oxo-7-[[(1S)-1-phenyl-2-prop-2-ynoxyethyl]carbamoyl]-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepin-4-yl]amino]-1-oxopropan-2-yl]-methylcarbamic acid?
The canonical SMILES for [(2S)-1-[[(4S,7S,9aS)-8,8-dimethyl-5-oxo-7-[[(1S)-1-phenyl-2-prop-2-ynoxyethyl]carbamoyl]-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepin-4-yl]amino]-1-oxopropan-2-yl]-methylcarbamic acid is C#CCOC[C@@H](NC(=O)[C@H]1N2C(=O)[C@@H](NC(=O)[C@H](C)N(C)C(=O)O)CCS[C@H]2CC1(C)C)c1ccccc1.
What is the InChIKey of [(2S)-1-[[(4S,7S,9aS)-8,8-dimethyl-5-oxo-7-[[(1S)-1-phenyl-2-prop-2-ynoxyethyl]carbamoyl]-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepin-4-yl]amino]-1-oxopropan-2-yl]-methylcarbamic acid?
The InChIKey is GEFSRSARSDNUEO-TXZRGUEPSA-N. The full InChI is InChI=1S/C27H36N4O6S/c1-6-13-37-16-20(18-10-8-7-9-11-18)29-24(33)22-27(3,4)15-21-31(22)25(34)19(12-14-38-21)28-23(32)17(2)30(5)26(35)36/h1,7-11,17,19-22H,12-16H2,2-5H3,(H,28,32)(H,29,33)(H,35,36)/t17-,19-,20+,21-,22+/m0/s1.
What are the key properties of [(2S)-1-[[(4S,7S,9aS)-8,8-dimethyl-5-oxo-7-[[(1S)-1-phenyl-2-prop-2-ynoxyethyl]carbamoyl]-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepin-4-yl]amino]-1-oxopropan-2-yl]-methylcarbamic acid?
[(2S)-1-[[(4S,7S,9aS)-8,8-dimethyl-5-oxo-7-[[(1S)-1-phenyl-2-prop-2-ynoxyethyl]carbamoyl]-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepin-4-yl]amino]-1-oxopropan-2-yl]-methylcarbamic acid has a molecular weight of 544.67 g/mol, XLogP of 2.07, 9 rotatable bonds, 3 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for [(2S)-1-[[(4S,7S,9aS)-8,8-dimethyl-5-oxo-7-[[(1S)-1-phenyl-2-prop-2-ynoxyethyl]carbamoyl]-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepin-4-yl]amino]-1-oxopropan-2-yl]-methylcarbamic acid is sourced from PubChem (CID 146596791), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).